Gangcheng Zhang

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Hossein Ardeschir Ghofrani, Gérald Simonneau, Andrea Maria D’Armini et al. · The Lancet Respiratory Medicine · 2017 · 262 citations

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

R. James White, Carlos Jerjes‐Sánchez, G. Meyer et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 142 citations · Full text

Impaired Cardiovascular Magnetic Resonance–Derived Rapid Semiautomated Right Atrial Longitudinal Strain Is Associated With Decompensated Hemodynamics in Pulmonary Arterial Hypertension

Shuang Leng, Dong Yang, Yang Wu et al. · Circulation Cardiovascular Imaging · 2019 · 70 citations · Full text

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension

Hang Zhang, Yongyue Wei, Caojin Zhang et al. · JACC: Cardiovascular Interventions · 2022 · 49 citations · Full text

Characteristics, goal‐oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry

Ruilin Quan, Gangcheng Zhang, Zaixin Yu et al. · Respirology · 2022 · 40 citations